Stay updated on Psilocybin Effects in Depressed Patients: Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Effects in Depressed Patients: Clinical Trial page.

Latest updates to the Psilocybin Effects in Depressed Patients: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew Revision: v3.4.2 is now shown and an older funding notice was removed, reflecting minor maintenance updates with no impact on trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA global site notice about potential information delays due to a lapse in government funding has been added, stating the NIH Clinical Center is open and directing users to opm.gov for updates; the page also shows a new revision label, v3.4.1, replacing 3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedExpanded the study record with additional metadata and MeSH terms (e.g., psilocybin, 5HT-2A, IPD) and removed No FEAR Act data.SummaryDifference48%

- Check35 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter text updated to show Revision: v3.3.3, with the earlier Revision: v3.3.2 entry and the HHS Vulnerability Disclosure link removed.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2; this reflects a version label change with no visible edits to core content or user-facing data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Effects in Depressed Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Effects in Depressed Patients: Clinical Trial page.